Universiti Teknologi Mara   Report issue

Academic/Hospital Phase 4
Founded: Shah Alam Malaysia (1956)

Organization Overview

First Clinical Trial
2014
NCT02389179
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Faculty of Dentistry, Universiti Teknologi Mara | Universiti Teknologi Mara

Active Ingredients

Drugs in Phase 4 Trials (1)

vitamin d3 (1 trial)

Drugs in Other Trials (2)

omeprazole (prilosec) (1 trial)

sodium fluoride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3